SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-C - Written communication relating to an issuer or third party:
SEC Accession No. 0001551152-18-000021
Filing Date
2018-04-26
Accepted
2018-04-26 07:50:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20180331x8kclassic.htm SC TO-C 32481
2 EXHIBIT 99.1 abbv-20180331xexhibit991cl.htm EX-99.1 288267
3 abbvieimage1a12.jpg GRAPHIC 15145
  Complete submission text file 0001551152-18-000021.txt   343230
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filed by) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Subject) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-C | Act: 34 | File No.: 005-87819 | Film No.: 18776197
SIC: 2834 Pharmaceutical Preparations